![]() |
시장보고서
상품코드
1663034
세계의 종양학 정보 시스템(OIS) 시장 규모, 점유율, 성장 분석(2025-2032년) : 제품 및 서비스별, 용도별, 최종 사용자별, 지역별 산업 예측Oncology Information Systems Market Size, Share, and Growth Analysis, By Product and Service (Software, Professional Services), By Application (Radiation Oncology, Medical Oncology), By End User, By Region - Industry Forecast 2025-2032 |
종양학 정보 시스템(OIS) 세계 시장 규모는 2023년에 72억 1,000만 달러로 평가되었고, 2024년 77억 8,000만 달러에서 2032년에는 142억 9,000만 달러로 성장해 예측기간(2025-2032년) 동안 CAGR 7.9%로 성장할 전망입니다.
종양학 정보 시스템(OIS)은 암 치료를 최적화하고 치료의 질과 환자의 안전성을 높이기 위해 조직 간의 데이터 교환을 촉진함으로써 병원, 진료소, 연구소에서 필수적입니다. 암 연구개발을 위한 정부 자금이 증가하는 가운데 효과적인 환자 정보 및 데이터 관리 솔루션에 대한 요구가 높아짐에 따라 OIS 시장의 큰 성장을 예상하고 있습니다. 이러한 수요의 급증은 특히 암 분야에서 다양한 OIS 소프트웨어 패키지에 대한 투자와 혁신적 기술의 개발을 촉진하고 있습니다. 또한, OIS는 적시에 정확한 치료를 제공하고 치료 결과를 평가하기 위한 종합적인 데이터로 임상의를 지원합니다. 헬스케어 예산이 확대되는 가운데 OIS 개발 기업에 대한 투자는 선진적인 의료계획 시스템에 대한 수요 증가를 충족하는 유리한 기회로 이어집니다.
Global Oncology Information Systems Market size was valued at USD 7.21 billion in 2023 and is poised to grow from USD 7.78 billion in 2024 to USD 14.29 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).
Oncology Information Systems (OIS) are becoming crucial for hospitals, clinics, and research labs by optimizing cancer care and facilitating inter-organizational data exchange to enhance treatment quality and patient safety. With growing government funding for oncology research and development, the OIS market is poised for significant growth, driven by the increasing need for effective patient information and data management solutions. This surge in demand is prompting investments in diverse OIS software packages and the development of innovative technologies, particularly in the cancer sector. Additionally, OIS ensures timely and accurate treatment delivery, supporting clinicians with comprehensive data for evaluating treatment outcomes. As healthcare budgets expand, investing in leading OIS developers presents lucrative opportunities to meet the evolving demand for advanced medical planning systems.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Information Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Oncology Information Systems Market Segments Analysis
Global Oncology Information Systems Market is segmented by Product and Service, Application, End User and region. Based on Product and Service, the market is segmented into Software and Professional Services. Based on Application, the market is segmented into Radiation Oncology, Medical Oncology and Surgical Oncology. Based on End User, the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions and Research Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Oncology Information Systems Market
The growing prevalence of cancer worldwide significantly propels the global oncology information systems market. The World Health Organization (WHO) highlights that cancer ranks among the foremost causes of mortality globally, underscoring the need for efficient treatment planning, data management, and patient care strategies. Oncology information systems enhance the functionality of oncology departments by enabling real-time information sharing, thereby increasing the precision of treatments. This improved accuracy not only optimizes patient outcomes but is also supported by advancements in pharmaceutical therapies. As such, the urgent demand for innovative solutions in cancer care continues to drive the market expansion for oncology information systems.
Restraints in the Global Oncology Information Systems Market
A significant challenge hindering the global adoption of Oncology Information Systems (OIS) is the substantial cost involved in their implementation and ongoing maintenance. Advanced OIS platforms necessitate considerable investments in infrastructure, software, and highly trained personnel, which can be a financial strain for smaller healthcare facilities, particularly in low- and middle-income countries. Additionally, the continuous need for maintenance, software updates, and robust cybersecurity measures further compounds these expenses, restricting the growth potential of the market in regions with limited resources. The high financial barrier poses a considerable restraint to the widespread acceptance and utilization of OIS in various healthcare environments.
Market Trends of the Global Oncology Information Systems Market
The global oncology information systems (OIS) market is witnessing a significant trend with the integration of artificial intelligence (AI) to enhance treatment accuracy and operational efficiency. AI-powered OIS can analyze extensive patient data, identify patterns, and forecast treatment outcomes, leading to more personalized and effective care. This technological advancement minimizes human error and accelerates decision-making, particularly in complex oncology cases. As demand for advanced cancer care grows, companies are heavily investing in AI capabilities to differentiate their offerings and gain a competitive edge in the market, driving the adoption of innovative solutions in oncology management worldwide.